These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 32735532)

  • 21. Double-edge sword roles of iron in driving energy production versus instigating ferroptosis.
    Zhang S; Xin W; Anderson GJ; Li R; Gao L; Chen S; Zhao J; Liu S
    Cell Death Dis; 2022 Jan; 13(1):40. PubMed ID: 35013137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis.
    Ma J; Zhang H; Chen Y; Liu X; Tian J; Shen W
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis at the nexus of metabolism and metabolic diseases.
    Li S; Zhang G; Hu J; Tian Y; Fu X
    Theranostics; 2024; 14(15):5826-5852. PubMed ID: 39346540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis in Friedreich's Ataxia: A Metal-Induced Neurodegenerative Disease.
    La Rosa P; Petrillo S; Fiorenza MT; Bertini ES; Piemonte F
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferroptotic stress promotes macrophages against intracellular bacteria.
    Ma R; Fang L; Chen L; Wang X; Jiang J; Gao L
    Theranostics; 2022; 12(5):2266-2289. PubMed ID: 35265210
    [No Abstract]   [Full Text] [Related]  

  • 26. GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis.
    Yu Y; Wang Q; Huang X; Li Z
    Int J Biol Macromol; 2024 Oct; 278(Pt 2):134779. PubMed ID: 39151850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation-Mediated Cell Death in Mice.
    Qi J; Kim JW; Zhou Z; Lim CW; Kim B
    Am J Pathol; 2020 Jan; 190(1):68-81. PubMed ID: 31610178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferritinophagy and ferroptosis in the management of metabolic diseases.
    Ajoolabady A; Aslkhodapasandhokmabad H; Libby P; Tuomilehto J; Lip GYH; Penninger JM; Richardson DR; Tang D; Zhou H; Wang S; Klionsky DJ; Kroemer G; Ren J
    Trends Endocrinol Metab; 2021 Jul; 32(7):444-462. PubMed ID: 34006412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of ferroptosis in non-alcoholic fatty liver disease.
    Wang S; Liu Z; Geng J; Li L; Feng X
    Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia.
    Wu T; Liang X; Liu X; Li Y; Wang Y; Kong L; Tang M
    Part Fibre Toxicol; 2020 Jul; 17(1):30. PubMed ID: 32652997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future.
    Fang W; Xie S; Deng W
    Cell Biol Toxicol; 2024 Mar; 40(1):17. PubMed ID: 38509409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferroptosis and its emerging roles in cardiovascular diseases.
    Li N; Jiang W; Wang W; Xiong R; Wu X; Geng Q
    Pharmacol Res; 2021 Apr; 166():105466. PubMed ID: 33548489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ferroptosis as a new therapeutic opportunity for nonviral liver disease.
    Jia M; Zhang H; Qin Q; Hou Y; Zhang X; Chen D; Zhang H; Chen Y
    Eur J Pharmacol; 2021 Oct; 908():174319. PubMed ID: 34252441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the study of ferroptosis and its relationship to autoimmune diseases.
    Dong W; Xu H; Wei W; Ning R; Chang Y
    Int Immunopharmacol; 2024 Oct; 140():112819. PubMed ID: 39096870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
    Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F
    Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney.
    Bayır H; Dixon SJ; Tyurina YY; Kellum JA; Kagan VE
    Nat Rev Nephrol; 2023 May; 19(5):315-336. PubMed ID: 36922653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells.
    Totsuka K; Ueta T; Uchida T; Roggia MF; Nakagawa S; Vavvas DG; Honjo M; Aihara M
    Exp Eye Res; 2019 Apr; 181():316-324. PubMed ID: 30171859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure.
    Cantrell AC; Zeng H; Chen JX
    J Cardiovasc Pharmacol; 2024 Jan; 83(1):23-32. PubMed ID: 37816193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.